A study by Malika Waschmann and co-authors compared the incidence of postpartum depression in mothers giving birth during the first year of the COVID-19 pandemic to those giving birth during the year preceding the pandemic.

OHSU’s multidisciplinary long-COVID program.

OPB interviews Bill Messer, M.D., Ph.D., about the long-term outlook for the COVID-19 pandemic. He says, “It may be that it becomes a seasonal respiratory virus but that it won’t carry with it the same horrific, devastating impact on our health care infrastructure going forward that it did early in the pandemic. We’re seeing more and more evidence to suggest that that is indeed a likely pattern.”

OHSU and Adventist Health Tillamook are teaming up to bring health care services directly to underserved residents in Tillamook and Columbia counties.

OHSU awards more than 1,100 degrees at its first in-person convocation ceremony in two years.

P. Barton Duell, M.D., calls non-alcoholic fatty liver disease a major threat and a “common condition that is often hidden or missed in routine medical care.”

Bethel University profiles Erik Brodt, M.D., and his formative experiences as an undergraduate there. Brodt says: “My goal is to eliminate American Indian and Alaska Native health inequities, and you can’t do that if you don’t have Native voices in the healthcare system and structure.”

OPB reports on labor action involving nurses at Providence Health System hospitals in Milwaukie, Oregon City and Beaverton.

As part of cancer survivor’s month, longtime chronic myeloid leukemia survivor Judy Orem shares her experience as one of the first participants in the Gleevec clinical trial. Orem describes the support group they started: “I kind of spearheaded that and ran that one. We did a newsletter. We met once a month. Dr. Druker would come to the meeting. He would explain to us why he wanted the counts to drop down, and then when getting started on the drug, he explained the whole process, what they were looking for, what they hoped to see.”